References
- Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission [internet]. Lancet. 2020;396(10248):413–446. [cited 2020 Aug 25]. doi: 10.1016/S0140-6736(20)30367-6
- Otaegui-Arrazola A, Amiano P, Elbusto A, et al. Diet, cognition, and Alzheimer’s disease: food for thought. Eur J Nutr. 2014;53(1):1–23. doi: 10.1007/s00394-013-0561-3
- Solfrizzi V, Panza F, Frisardi V, et al. Diet and Alzheimer’s disease risk factors or prevention: the current evidence [internet]. Expert Rev Neurother. 2011;11(5):677–708. [cited 2021 Apr 9]. Available from: https://pubmed.ncbi.nlm.nih.gov/21539488/
- Zhang Y, Chen J, Qiu J, et al. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. Am J Clin Nutr. 2016;103:330–340. doi: 10.3945/ajcn.115.124081
- Shah R. The role of nutrition and diet in Alzheimer disease: a systematic review. J Am Med Dir Assoc Elsevier Inc. 2013;14(6):398–402. doi: 10.1016/j.jamda.2013.01.014
- Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009;5(3):140–152. doi: 10.1038/ncpneuro1044
- Shahidi F, Ambigaipalan P. Omega-3 polyunsaturated fatty acids and their health benefits. Annu Rev Food Sci Technol [Internet]. 2018 [cited 2022 Nov 16];9:345–381. Available from: https://pubmed-ncbi-nlm-nih-gov.ezproxy.javeriana.edu.co/29350557/
- Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr. 2012;3(1):1–7. doi: 10.3945/an.111.000893
- Surette ME. Mechanisms and innovations: the science behind dietary omega-3 fatty acids. 2008 [cited 2022 Nov 16]; CMAJ. 178(2):177. Available from: /pmc/articles/PMC2174995/
- Calder PC. n−3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006 cited 2022 Nov 16;83(6):1505S–1519S. Available from https://pubmed.ncbi.nlm.nih.gov/16841861/
- Simopoulos AP. An increase in the omega-6/Omega-3 fatty acid ratio increases the risk for obesity [internet]. Nutrients. 2016 [cited 2021 Sep 27];8(3):128. /pmc/articles/PMC4808858/
- Taber L, Chiu CH, Whelan J. Assessment of the arachidonic acid content in foods commonly consumed in the American diet. Lipids [Internet]. 1998 [cited 2022 Nov 16];33:1151–1157. Available from: https://pubmed.ncbi.nlm.nih.gov/9930399/
- Whelan J, Rust C. Innovative dietary sources of n-3 fatty acids. Annu Rev Nutr [Internet]. 2006 [cited 2022 Nov 16];26:75–103. Available from: https://pubmed.ncbi.nlm.nih.gov/16848701/
- Leaf DA, Hatcher L. The effect of lean fish consumption on triglyceride levels. Phys Sportsmed [Internet]. 2009 [cited 2022 Nov 16];37:37–43. Available from: https://pubmed.ncbi.nlm.nih.gov/20048486/
- Mann NJ, O’Connell SL, Baldwin KM, et al. Effects of seal oil and tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects. Lipids [Internet]. 2010;45(8):669–681. [cited 2022 Nov 16]. Available from: https://pubmed.ncbi.nlm.nih.gov/20652432/
- Harris WS, Pottala JV, Sands SA, et al. Comparison of the effects of fish and fish-oil capsules on the n–3 fatty acid content of blood cells and plasma phospholipids. Am J Clin Nutr. 2007;86(6):1621–1625. [cited 2023 Jan 12]. Available from: https://pubmed.ncbi.nlm.nih.gov/18065578/
- Lacombe RJS, Chouinard-Watkins R, Bazinet RP. Brain docosahexaenoic acid uptake and metabolism. Mol Aspects Med. 2018 [cited 2023 Nov 16];64:109–134. Available from: https://pubmed.ncbi.nlm.nih.gov/29305120/
- Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science [Internet]. 2001 [cited 2022 Nov 16];294(5548):1871–1875. Available from: https://pubmed.ncbi.nlm.nih.gov/11729303/
- Vila IK, Chamma H, Steer A, et al. STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses. Cell Metab [Internet]. 2022;34(1):125. [cited 2024 Jan 15]. Available from: /pmc/articles/PMC8733004/
- Sun Q, Ma J, Campos H, et al. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr. 2007;86(1):74–81. doi: 10.1093/ajcn/86.1.74
- Jevtic S, Sengar AS, Salter MW, et al. The role of the immune system in Alzheimer disease: etiology and treatment. Ageing Res Rev. 2017;40:84–94. doi: 10.1016/j.arr.2017.08.005
- Susai SR, Healy C, Mongan D, et al. Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: a mass spectrometry-based investigation in subjects at clinical high-risk for psychosis. Transl Psychiatry [Internet]. 2022;12(1):20. [cited 2024 Jan 15]. Available from: /pmc/articles/PMC9616837/
- Hopperton KE, Trépanier MO, Giuliano V, et al. Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice. J Neuroinflammation [Internet]. 2016 [cited 2024 Jan 15];13(1): Available from: /pmc/articles/PMC5041295/
- Jafarzadeh A, Sheikhi A, Jafarzadeh Z, et al. Differential roles of regulatory T cells in Alzheimer’s disease. Cell Immunol. 2023;393–394:104778. doi: 10.1016/j.cellimm.2023.104778
- Gutiérrez S, Svahn SL, Johansson ME. Effects of omega-3 fatty acids on immune cells. Int J Mol Sci [Internet]. 2019 [cited 2024 Jan 15];20(20):5028. Available from /pmc/articles/PMC6834330/
- Williams-Bey Y, Boularan C, Vural A, et al. Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-κB activation and enhancing autophagy. PLoS One. 2014;9(6):97957. cited 2024 Jan 15. Available from: /pmc/articles/PMC4049592/
- Canhada S, Castro K, Perry IS, et al. Omega-3 fatty acids’ supplementation in Alzheimer’s disease: a systematic review. Nutr Neurosci. 2018;21(8):529–538. Taylor and Francis Ltd. doi: 10.1080/1028415X.2017.1321813
- Decsi T, Kennedy K. Sex-specific differences in essential fatty acid metabolism. Am J Clin Nutr. 2011;94. doi: 10.3945/ajcn.110.000893
- Lin PY, Cheng C, Satyanarayanan SK, et al. Omega-3 fatty acids and blood-based biomarkers in Alzheimer’s disease and mild cognitive impairment: a randomized placebo-controlled trial. Brain, Behavior, And Immunity 2022 [cited 2023 Apr 24];99:289–298. Available from: https://pubmed.ncbi.nlm.nih.gov/34755655/
- Arellanes IC, Choe N, Solomon V, et al. Brain delivery of supplemental docosahexaenoic acid (DHA): a randomized placebo-controlled clinical trial. EBioMedicine [Internet] 2020 [cited 2023 May 15];59:102883. Available from: http://www.thelancet.com/article/S2352396420302589/fulltext
- Torres-Mendoza BMG, Ortiz GG, Sánchez-Romero L, et al. Dietary fish oil increases catalase activity in patients with probable Alzheimer’s disease. Nutrición Hospitalaria. 2022;39(6):1364–1368. doi: 10.20960/nh.04153
- Tamtaji OR, Taghizadeh M, Aghadavod E, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson’s disease: a randomized, double-blind, placebo-controlled trial. Clin Neurol Neurosur. 2019;176:116–121. doi: 10.1016/j.clineuro.2018.12.006
- Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study. Arch Neurol [Internet]. 2006 [cited 2023 Jan 17];63(10):1402–1408. Available from:https://pubmed.ncbi.nlm.nih.gov/17030655/
- Chiu CC, Su KP, Cheng TC, et al. The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32(6):1538–1544. [cited 2023 Jan 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/18573585/
- Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA [Internet]. 2010;304(17):1903–1911. [cited 2023 Jan 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/21045096/
- Scheltens P, Twisk JWR, Blesa R, et al. Efficacy of Souvenaid in mild Alzheimer’s disease: results from a randomized, controlled trial. JAD. 2012;31(1):225–236. [cited 2023 Jan 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/22766770/
- Soininen H, Solomon A, Visser PJ, et al. 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer’s disease. Alzheimer’s Dementia. 2021;17(1):29–40. [cited 2024 Jan 12]. Available from: https://pubmed.ncbi.nlm.nih.gov/32920957/
- Shah RC, Kamphuis PJ, Leurgans S, et al. The S-Connect study: results from a randomized, controlled trial of souvenaid in mild-to-moderate Alzheimer’s disease. Alzheimers Res Ther [Internet]. 2013;5(6):59. [cited 2023 Nov 16]. Available from: /pmc/articles/PMC3978853/
- Shinto L, Quinn J, Montine T, et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer’s disease. JAD. 2014;38(1):111–120. [cited 2023 Jan 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/24077434/
- Phillips MA, Childs CE, Calder PC, et al. No effect of omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impairment and probable Alzheimer’s disease: a randomised controlled trial. Int J Mol Sci [Internet] 2015 [cited 2023 Jan 17];16:24600–24613. Available from: https://pubmed.ncbi.nlm.nih.gov/26501267/
- Punia S, Sandhu KS, Siroha AK, et al. Omega 3-metabolism, absorption, bioavailability and health benefits–A review. Pharmanutrition. 2019;10:100162. doi: 10.1016/j.phanu.2019.100162
- Brown AJ, Pang E, Roberts DCK. Erythrocyte eicosapentaenoic acid versus docosahexaenoic acid as a marker for fish and fish oil consumption. Prostaglandins Leukot Essent Fatty Acids [Internet]. 1991 [cited 2023 Apr 16];44:103–106. Available from: https://pubmed.ncbi.nlm.nih.gov/1836062/
- Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci [Internet]. 2015 [cited 2023 Apr 16];7. Available from: /pmc/articles/PMC4404917/
- Lemaitre RN, Tanaka T, Tang W, et al. Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE consortium. PLoS Genet [Internet]. 2011;7(7):e1002193. [cited 2023 Apr 16]. Available from: https://pubmed.ncbi.nlm.nih.gov/21829377/
- Plourde M, Vohl MC, Vandal M, et al. Plasma n -3 fatty acid response to an n -3 fatty acid supplement is modulated by apoE ɛ4 but not by the common PPAR-α L162V polymorphism in men. Br J Nutr [Internet]. 2009;102(8):1121–1124. [cited 2023 Apr 16]. Available from: https://pubmed.ncbi.nlm.nih.gov/19828088/
- Brenna JT, Salem N, Sinclair AJ, et al. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins, Leukotrienes And Essential Fatty Acids. 2009;80(2–3):85–91. [cited 2023 Apr 16]. Available from: https://pubmed.ncbi.nlm.nih.gov/19269799/
- Wang X, Hjorth E, Vedin I, et al. Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study. J Lipid Res [Internet] 2015 [cited 2022 Nov 28];56:674–681. Available from: https://pubmed.ncbi.nlm.nih.gov/25616438/
- Rangel-Huerta OD, Aguilera CM, Mesa MD, et al. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr. 2012;107(Suppl 2):S159–S170. [cited 2022 Nov 28]. InternetAvailable from: https://pubmed.ncbi.nlm.nih.gov/22591890/
- Calder PC. Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol [Internet]. 2013 [cited 2024 Jan 22];75(3):645. Available from /pmc/articles/PMC3575932/
- Wang X, Zhu M, Hjorth E, et al. Resolution of inflammation is altered in Alzheimer’s disease. Alzheimer’s Dementia. 2015;11(1):40–50.e2. [cited 2022 Nov 28]. Available from: https://pubmed.ncbi.nlm.nih.gov/24530025/
- Lukiw WJ, Cui JG, Marcheselli VL, et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Investig. 2005;115(10):2774–2783. [cited 2022 Nov 28]. Available from: https://pubmed.ncbi.nlm.nih.gov/16151530/
- Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature [Internet]. 2014 [[cited 2022 Nov 28]];510:92–101. Available from: https://pubmed.ncbi.nlm.nih.gov/24899309/
- Giltay EJ, Gooren LJG, Toorians AWFT, et al. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am J Clin Nutr [Internet] 2004 [cited 2023 Apr 16];80:1167–1174. Available from: https://pubmed.ncbi.nlm.nih.gov/15531662/
- Burdge GC, Wootton SA. Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr [Internet]. 2002 [cited 2023 Apr 16];88(4):411–420. Available from https://pubmed.ncbi.nlm.nih.gov/12323090/
- Bakewell L, Burdge GC, Calder PC. Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets. Br J Nutr [Internet]. 2006 [[cited 2023 Apr 16]];96:93. Available from: https://pubmed.ncbi.nlm.nih.gov/16869996/
- Walker CG, Browning LM, Mander AP, et al. Age and sex differences in the incorporation of EPA and DHA into plasma fractions, cells and adipose tissue in humans. Br J Nutr [Internet]. 2014;111(4):679. [cited 2021 Sep 27]. Available from: /pmc/articles/PMC4351921/
- Da Boit M, Sibson R, Sivasubramaniam S, et al. Sex differences in the effect of fish-oil supplementation on the adaptive response to resistance exercise training in older people: a randomized controlled trial. Am J Clin Nutr [Internet]. 2017;105(1):151. [cited 2022 Nov 28]. Available from: /pmc/articles/PMC5183731/
- Childs CE, Romeu-Nadal M, Burdge GC, et al. Gender differences in the n-3 fatty acid content of tissues. Proc Nutr Soc [Internet] 2008 [cited 2023 Apr 16];67:19–27. Available from: https://pubmed.ncbi.nlm.nih.gov/18234128/
- González-Bengtsson A, Asadi A, Gao H, et al. Estrogen enhances the expression of the polyunsaturated fatty acid elongase Elovl2 via ERα in breast cancer cells. PloS One. 2016;11(10):e0164241. [cited 2023 Apr 18]. Available from: /pmc/articles/PMC5082882/
- Alessandri JM, Extier A, Langelier B, et al. Estradiol favors the formation of eicosapentaenoic acid (20:5n-3) and n-3 docosapentaenoic acid (22:5n-3) from alpha-linolenic acid (18:3n-3) in SH-SY5Y neuroblastoma cells. Lipids [Internet]. 2008;43(1):19–28. [cited 2023 Apr 20]. Available from: https://www.researchgate.net/publication/5931564_Estradiol_Favors_the_Formation_of_Eicosapentaenoic_Acid_205n-3_and_n-3_Docosapentaenoic_Acid_225n-3_from_Alpha-Linolenic_Acid_183n-3_in_SH-SY5Y_Neuroblastoma_Cells
- Giltay EJ, Duschek EJJ, Katan MB, et al. Raloxifene and hormone replacement therapy increase arachidonic acid and docosahexaenoic acid levels in postmenopausal women. J Endocrinol [Internet] 2004 [cited 2023 Apr 19];182:399–408. Available from: https://pubmed.ncbi.nlm.nih.gov/15350182/
- Stark KD, Holub BJ. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr [Internet]. 2004 [[cited 2022 Nov 28]];79:765–773. Available from: https://pubmed.ncbi.nlm.nih.gov/15113713/
- Mingay E, Veysey M, Lucock M, et al. Sex-dependent association between omega-3 index and body weight status in older Australians. J Nutr Intermed Metab. 2016;5:70–77. doi: 10.1016/j.jnim.2016.04.001
- Simopoulos AP. Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol Neurobiol [Internet]. 2011 [cited 2023 Jan 12];44(2):203–215. Available from https://pubmed.ncbi.nlm.nih.gov/21279554/
- Hibbeln JR, Nieminen LRG, Blasbalg TL, et al. Healthy intakes of n−3 and n–6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006;83(6):1483S–1493S. [cited 2023 Jan 12]. Available from: https://pubmed.ncbi.nlm.nih.gov/16841858/
- Trumbo P, Schlicker S, Yates AA, et al. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc [Internet] 2002 [cited 2023 Jan 12];102:1621–1630. Available from: https://pubmed.ncbi.nlm.nih.gov/12449285/
- Stark KD, Van Elswyk ME, Higgins MR, et al. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Prog Lipid Res. 2016;63:132–152. doi: 10.1016/j.plipres.2016.05.001
- Raatz SK, Redmon JB, Wimmergren N, et al. Enhanced absorption of omega-3 fatty acids from emulsified compared with encapsulated fish oil (). J Am Diet Assoc [Internet]. 2009;109(6):1076. [cited 2023 Jan 12]. Available from: /pmc/articles/PMC2701654/
- Castellanos TL, Rodriguez DM. El efecto de omega 3 en la salud humana y consideraciones en la ingesta. Rev Chil Nutr. 2015 [cited 2022 Nov 28];42(1):90–95. Available from http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75182015000100012&lng=es&nrm=iso&tlng=es
- Araya-Quintanilla F, Gutiérrez-Espinoza H, Sánchez-Montoya U, et al. Effectiveness of omega-3 fatty acid supplementation in patients with Alzheimer disease: a systematic review and meta-analysis. Neurología (English Edition). 2020;35(2):105–114. doi: 10.1016/j.nrleng.2017.07.014
- Dempsey M, Rockwell MS, Wentz LM. The influence of dietary and supplemental omega-3 fatty acids on the omega-3 index: a scoping review. Front Nutr. 2023 [[cited 2023 Nov 23]];10. Available from: /pmc/articles/PMC9892774/
- Cunnane SC, Plourde M, Pifferi F, et al. Fish, docosahexaenoic acid and Alzheimer’s disease. Prog Lipid Res [Internet] 2009 [cited 2022 Nov 18];48:239–256. Available from: https://pubmed.ncbi.nlm.nih.gov/19362576/
- Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol [Internet]. 2003;60(7):940–946. [cited 2022 Nov 18]. Available from: https://pubmed.ncbi.nlm.nih.gov/12873849/
- Avallone R, Vitale G, Bertolotti M. Omega-3 fatty acids and neurodegenerative diseases: New evidence in clinical trials. Int J Mol Sci MDPI AG. 2019;20(17):4256. doi: 10.3390/ijms20174256
- Nishihira J, Tokashiki T, Higashiuesato Y, et al. Associations between serum omega-3 fatty acid levels and cognitive functions among community-dwelling octogenarians in Okinawa, Japan: the KOCOA study. J Alzheimers Dis [Internet]. 2016;51(3):857. [cited 2023 Apr 16]. Available from: /pmc/articles/PMC4816662/
- Lukaschek K, Von Schacky C, Kruse J, et al. Cognitive impairment is associated with a Low Omega-3 Index in the elderly: results from the KORA-Age study. Dement Geriatr Cognit Disord [Internet] 2016 [cited 2023 Apr 16];42:236–245. Available from: https://www.karger.com/Article/FullText/448805
- Shinto L, Lahna D, Murchison CF, et al. Oxidized products of omega-6 and omega-3 long chain fatty acids are associated with increased white matter hyperintensity and poorer executive function performance in a cohort of cognitively normal hypertensive older adults. J Alzheimers Dis [Internet]. 2020;74(1):65. [cited 2024 Jan 15]. Available from: /pmc/articles/PMC8597742/
- Sun CP, Zhang XY, Morisseau C, et al. Discovery of soluble epoxide hydrolase inhibitors from chemical synthesis and natural products. J Med Chem. 2021;64(1):184. [cited 2024 Jan 16]. Available from: /pmc/articles/PMC7942193/
- Mazereeuw G, Lanctôt KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging Elsevier Inc. 2012;33(7):e1482.17–.e1482.29. doi: 10.1016/j.neurobiolaging.2011.12.014
- Wu S, Ding Y, Wu F, et al. Omega-3 fatty acids intake and risks of dementia and Alzheimer’s disease: a meta-analysis. Neurosci Biobehav Rev Elsevier Ltd. 2015;48:1–9. doi: 10.1016/j.neubiorev.2014.11.008
- Burckhardt M, Herke M, Wustmann T, et al. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev. 2016;2016(4). doi: 10.1002/14651858.CD009002.pub3
- Omega-3 fatty acids - StatPearls - NCBI bookshelf [internet]. [cited 2023 Jan 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK564314/?report=printable.
- Villani AM, Crotty M, Cleland LG, et al. Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature. BMC Geriatr [Internet]. 2013;13(1):41. [cited 2023 Jan 12]. Available from: /pmc/articles/PMC3664575/
- Araya-Quintanilla F, Gutiérrez-Espinoza H, Sánchez-Montoya U, et al. Effectiveness of omega-3 fatty acid supplementation in patients with Alzheimer disease: a systematic review and meta-analysis. Neurología (English Edition). 2020;35(2):105–114. [cited 2021 Oct 24]. Available from: https://pubmed.ncbi.nlm.nih.gov/28986068/
- Kotani S, Sakaguchi E, Warashina S, et al. Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res. 2006;56(2):159–164. doi: 10.1016/j.neures.2006.06.010
- Wood AHR, Chappell HF, Zulyniak MA. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer’s disease. Eur J Nutr. 2022;61(2):589–604. Springer Science and Business Media Deutschland GmbH. doi: 10.1007/s00394-021-02655-4
- Int Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med. 2001;345(21):1515–1521. doi: 10.1056/NEJMoa010178